B

Bestride

Asia, Beijing, China, Beijing

Description

Bestride Is an investment Firm.

Investor Profile

Bestride has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bestride frequently co-invest with?

Yuexiu Group
Asia, Hong Kong Island, Hong Kong, Wan Chai
Co-Investments: 1
CCBT Private Equity
Asia, Beijing, China, Beijing
Co-Investments: 1
CE
Asia, Fujian, China, Xiamen
Co-Investments: 1
Dingxin Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
CS
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Exome Asset Management
North America, New York, United States, New York
Co-Investments: 1
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 1

Which angels does Bestride often collaborate with?

SI
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Bestride?

IMPACT Therapeutics

Nanjing, Jiangsu, China

IMPACT Therapeutics is a therapeutics company dedicated to the development of similar drugs to treat cancer.

BiotechnologyPharmaceuticalTherapeutics
Series DMar 14, 2022